RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots
Njepuome, N. A., Hopkins, D. R., Richards, F. O., Anagbogu, I. N., Pearce, P. O., Jibril, M. M., Okoronkwo, C., Sofola, O. T., Withers, P. C., Ruiz-Tiben, E., Miri, E. S., Eigege, A., Emukah, E. C., Nwobi, B. C., & Jiya, J. Y. (2009). Nigeria's war on terror: Fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots. American Journal of Tropical Medicine and Hygiene, 80(5), 691-698.
Africa's populous country, Nigeria, contains or contained more cases of dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis than any other African nation and ranks or ranked first (dracunculiasis, onchocerciasis, schistosomiasis) or third (lymphatic filariasis) in the world for the same diseases. After beginning village-based interventions against dracunculiasis 20 years ago and confronting onchocerciasis a few years later, Nigeria has nearly eliminated dracunculiasis and has provided annual mass drug administration for onchocerciasis to over three quarters of that at-risk population for 7 years. With assistance from The Carter Center, Nigeria began treating lymphatic filariasis and schistosomiasis in two and three states, respectively, over the past decade, while conducting pioneering operational research as a basis for scaling up interventions against those diseases, for which much more remains to be done. This paper describes the status of Nigeria's struggles against these four neglected tropical diseases and discusses challenges and plans for the future.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.